Growth Metrics

Ultragenyx Pharmaceutical (RARE) Net Income towards Common Stockholders (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -43.91%
Dec 31, 2025 28.74%
Sep 30, 2025 -56.95%
Jun 30, 2025 23.87%
Mar 31, 2025 -135.21%
Dec 31, 2024 421.16%
Sep 30, 2024 -1.46%
Jun 30, 2024 22.90%
Mar 31, 2024 -38.15%
Dec 31, 2023 22.61%
Sep 30, 2023 0.11%
Jun 30, 2023 2.53%
Mar 31, 2023 -6.84%
Dec 31, 2022 37.39%
Sep 30, 2022 -54.97%
Jun 30, 2022 -3.84%
Mar 31, 2022 -22.06%
Dec 31, 2021 -70.95%
Sep 30, 2021 40.37%
Jun 30, 2021 10.07%
Mar 31, 2021 -466.99%
Dec 31, 2020 65.12%
Sep 30, 2020 -371.95%
Jun 30, 2020 121.27%
Mar 31, 2020 -26.89%
Dec 31, 2019 16.98%
Sep 30, 2019 -13.94%
Jun 30, 2019 -2.50%
Mar 31, 2019 -10.17%
Dec 31, 2018 -0.59%
Sep 30, 2018 -65.59%
Jun 30, 2018 -274.29%
Mar 31, 2018 130.88%
Dec 31, 2017 -23.67%
Sep 30, 2017 -8.69%
Jun 30, 2017 -6.74%
Mar 31, 2017 4.16%
Dec 31, 2016 -9.78%
Sep 30, 2016 -14.03%
Jun 30, 2016 -8.14%
Mar 31, 2016 4.71%
Dec 31, 2015 -40.69%
Sep 30, 2015 -32.26%
Jun 30, 2015 -39.84%
Mar 31, 2015 -26.76%
Dec 31, 2014 -6.92%
Sep 30, 2014 -15.30%
Jun 30, 2014 0.33%
Mar 31, 2014 -43.99%
Dec 31, 2013 -23.05%
Sep 30, 2013 11.09%
Jun 30, 2013 -27.98%